Navigating Biotech Turbulence

This chapter explores the challenges faced by biotech companies, particularly focusing on Third Harmonic Bio's struggle as it contemplates dissolution. It emphasizes the difficult decision-making process executives endure amid setbacks, highlighting the delicate balance between transparency and operational reality. The discussion advocates for honest leadership and open communication, promoting a shift in industry practices when confronting adversity.